Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018
Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006
Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Reducing the decline of FEV1 after a 4-year therapy with montelukast in patients with bronchial asthma Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
Safety of inhaled corticosteroids reduction in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004
Reduction of respiratory resistance after fluticasone inhaled therapy in asthmatic preschool children Source: Eur Respir J 2004; 24: Suppl. 48, 166s Year: 2004
Effect of inhaled steroids on lung function in young children: a cohort study Source: Eur Respir J 2004; 23: 869-875 Year: 2004
FEV1 response to albuterol is not affected by inhaled human insulin (Exubera®) use in subjects with mild-to-moderate asthma Source: Eur Respir J 2006; 28: Suppl. 50, 840s Year: 2006
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
Airway resistance variability and response to bronchodilator in children with asthma Source: Eur Respir J 2007; 30: 260-268 Year: 2007
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007
Effects of Asian dust events on peak expiratory flow and respiratory symptoms in subjects with bronchial asthma: a three month prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 301s Year: 2003
Peak inspiratory flow rate during inhalation corticosteroid therapy in adult asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009
Maintenance plus as-needed budesonide/formoterol vs salmeterol/fluticasone in a real-life setting Source: Annual Congress 2005 - Combination therapy for asthma. Which, why and how? Year: 2005
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo Source: Eur Respir J 2006; 28: Suppl. 50, 764s Year: 2006
Meta-analysis of inhaled corticosteroids response in children with asthma. Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019
Reduction of inhaled corticosteroids in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007